|
See below for a listing of the presenters and abstracts from the Biotech 2009 Innovation Corridor. Click on the abstract title to view the abstract.
Congratulations to the Innovation Corridor Poster Winners.
Innovation Corridor Session I
Monday, November 16, 2009
8:30 a.m. – 11:30 a.m.
|
Name/Institution
|
Title
|
Category
|
Poster Number
|
|
Innovation Corridor Poster Winner
Hector Alila
Esperance Pharmaceuticals, Inc.
|
EP-100 is a Targeted Peptide for Treatment of Cancers that Over-express LHRHReceptors
|
Technologies and Targets for the Treatments of Tomorrow
|
1
|
|
Nat Cooperman
X-dicator Corp.
|
Vaccines and Biologicals Freeze and Overheat Indicator
|
Devices, Diagnostics, and Drug Development Tools
|
2
|
|
Effat S. Emamian, M.D
Advanced Technologies for Novel Therapeutics, LLC (ATNT, LLC)
|
A Novel Fault Diagnosis Engineering Technology for Identification of Therapeutic Targets
|
Technologies and Targets for the Treatments of Tomorrow
|
3
|
|
Steven H. Ginsberg, M.D.
UMDNJ-Robert Wood Johnson Medical School
|
Bracket to Simplify Invasive Pressure Monitoring
|
Devices, Diagnostics, and Drug Development Tools
|
4
|
|
Innovation Corridor Poster Winner
Jeffrey Holt
The Commonwealth Medical College, Scranton PA
|
IHC Method to Diagnose BRCA Mutant Breast Cancer and Determine Mutations
|
Devices, Diagnostics, and Drug Development Tools
|
5
|
|
Jerome A. Langer
UMDNJ-Robert Wood Johnson Medical School, Department of Molecular Genetics, Microbiology & Immunology
|
Novel Type I Interferon Antagonists
|
Technologies and Targets for the Treatments of Tomorrow
|
6
|
|
Anthony E. Klon
Locus Pharmaceuticals, Inc.
|
The Successful Use of Charrette™ to Prospectively Design Novel and Potent Inhibitors of 5’-AMP-Activated Protein Kinase, AMPK
|
Technologies and Targets for the Treatments of Tomorrow
|
7
|
|
Matthew Kuruc
ProFACT Proteomics, Inc
|
Molecular Profiling with SeraFILE – Prospecting for Conformational Variants
|
Devices, Diagnostics, and Drug Development Tools
|
8
|
|
Agis Kydonieus, Ph.D.
Samos Pharmaceuticals, LLC
|
Multi-day Oral Delivery of Drugs from Administration of a Single Tablet
|
Novel Therapeutic Agents and Delivery Systems
|
9
|
|
Eric Lagasse, Ph.D.
University of Pittsburgh
|
Lymph Nodes as Sites for Tissue Regeneration
|
Technologies and Targets for the Treatments of Tomorrow
|
10
|
|
Troy Messick, Ph.D.
Vironika, LLC
|
Novel Inhibitors of Latent Epstein-Barr Virus Infection
|
Technologies and Targets for the Treatments of Tomorrow
|
11
|
|
Anna P. M. Michel
Princeton University
|
Development of a Quantum Cascade Laser-based Sensor for Detection of CO2 in the Human Fingertip
|
Devices, Diagnostics, and Drug Development Tools
|
12
|
|
Maricarmen D. Planas-Silva, Ph.D., MBA, GCCR
BioCells2Cure
|
Drug Sensitivity Assay for Hormone-Resistant Breast Cancer
|
Devices, Diagnostics, and Drug Development Tools
|
13
|
|
Sam Rothstein
University of Pittsburgh
|
Engineering Sustained Release in Therapeutics
|
Novel Therapeutic Agents and Delivery Systems
|
14
|
|
Anil B. Shrirao
New Jersey Institute of Technology
|
Hybrid Micofluidic Device with Integrated 3D Electrodes for Live-Cell Detection
|
Technologies and Targets for the Treatments of Tomorrow
|
15
|
|
Riju Singhal
Drexel University
|
Multi-functional Carbon Nanopipettes for Cellular Probing
|
Devices, Diagnostics, and Drug Development Tools
|
16
|
|
Norio Takizawa
TRIM-edicine, Inc.
|
The Bfl1 Amphipathic Tail-anchoring Peptide (ATAP) as a Therapeutic Agent to Induce Apoptosis in Cancer Cells
|
Technologies and Targets for the Treatments of Tomorrow
|
17
|
|
Innovation Corridor Poster Winner
Hock S. Tan
Bionex Pharmaceuticals LLC
|
Oral Transmucosal Drug Delivery System for Nicotine
|
Novel Therapeutic Agents and Delivery Systems
|
18
|
Innovation Corridor Session II
Tuesday, November 17, 2009
8:30 a.m. – 11:30 a.m.
|
Name/Institution
|
Title
|
Category
|
Poster Number
|
|
Pamela L. Beatty, Ph.D.
University of Pittsburgh School of Medicine
|
Cancer Vaccines and Immunotherapy
|
Technologies and Targets for the Treatments of Tomorrow
|
1
|
|
Stephanie J. Budijono
Princeton University
|
Advances in Biocompatible Composite Nanoparticles for Improved Photodynamic Cancer Therapy
|
Technologies and Targets for the Treatments of Tomorrow
|
2
|
|
Innovation Corridor Poster Winner
Frank Chang
Proplex Technologies / Temple University
|
ELISA Method For Detection of Breast Cancer
|
Devices, Diagnostics, and Drug Development Tools
|
3
|
|
Suzanne M. D’Addio
Princeton University Department of Chemical Engineering
|
Nanoscale Drug Cocktails for the Enhanced Treatment of Tuberculosis
|
Novel Therapeutic Agents and Delivery Systems
|
4
|
|
Shengkan Victor Jin
UMDNJ-Robert Wood Johnson Medical School
|
Inhibition of Autophagy: A Novel Approach to Treat Obesity and Type II Diabetes
|
Novel Therapeutic Agents and Delivery Systems
|
5
|
|
Shinobu Kitamura
Medical & Biological Laboratories, Co., Ltd.
|
RiboCluster ProfilerTM RIP-Assay Kit and RIP-Certified Antibody Immunological Tools to Unravel Posttranscriptional Regulatory Networks
|
Technologies and Targets for the Treatments of Tomorrow
|
6
|
|
Qing Liu
3D Biotek, LLC
|
A Novel Rapid Polymer Vascular Stent Fabrication System
|
Devices, Diagnostics, and Drug Development Tools
|
7
|
|
Innovation Corridor Poster Winner
Anne-Marie Maman
Oxygense, LLC
|
System for Real-Time Measurement of Tissue pO2 and pCO2 in Critically Ill Patients
|
Devices, Diagnostics, and Drug Development Tools
|
8
|
|
Adam G. Marsh, Ph.D.
University of Delaware
|
Rational Antibiotic Drug Design: Identification of Sensitive Proteins and Domains for Drug Targeting.
|
Devices, Diagnostics, and Drug Development Tools
|
9
|
|
Alexey Melishchuk
Drexel University
|
Anastomotic Device for Small Lumen Structures
|
Devices, Diagnostics, and Drug Development Tools
|
10
|
|
Dr. D. Bruce Merrifield
Pridco Management LLC
|
Sobrex Elimination of Alcohol and Nicotine Addiction
|
Novel Therapeutic Agents and Delivery Systems
|
11
|
|
M. Maral Mouradian, M.D.
UMDNJ–Robert Wood
Johnson Medical School
|
Micro-RNA Mediated Down-Regulation of α-Synuclein as a Novel Neuroprotective Strategy for Parkinson's Disease
|
Technologies and Targets for the Treatments of Tomorrow
|
12
|
|
Asit B. Panja
AlfaGene Bioscience, Inc.
|
Multiple Applications of a Novel Human Gastro-Intestinal Stem Cell (HGISC) Based R&D Platform in Drug Discovery and Development
|
Devices, Diagnostics, and Drug Development Tools
|
13
|
|
Melvin Reichman, Ph.D.
Lankenau Chemical Genomics Center, Inc.
|
Innovative Products for Accelerating Exploration of Chemical and Biological Space
|
Devices, Diagnostics, and Drug Development Tools
|
14
|
|
Christopher Rusconi, Ph.D.
Regado Biosciences, Inc
|
Aptamer-Active Control Agent Pairs as a Discovery Platform for the Generation of Safer Antithrombotic Agents
|
Technologies and Targets for the Treatments of Tomorrow
|
15
|
|
Innovation Corridor Poster Winner
Charles Sfeir, DDS, Ph.D
Prashant Kumta, Ph.D
University of Pittsburgh
|
Novel Synthetic Porous and Biodegradable Bone Cement for Orthopaedic and Craniofacial Regeneration
|
Technologies and Targets for the Treatments of Tomorrow
|
16
|
|
Paul M. Simon, Ph.D.
Augmenta Biologicals, LLC
|
Self-Adjuvanting Immunization by Red Blood Cell Opsonization In Vivo
|
Technologies and Targets for the Treatments of Tomorrow
|
17
|
|
Bryan P. Tracy
Elcriton Inc.
|
Elcriton – Engineering to Sustain the Energy, Chemical, Pharmaceutical and Medical Device Industries of Tomorrow
|
Technologies and Targets for the Treatments of Tomorrow
|
18
|
|
Alexandra Vamvakidou
Integromics, Inc.
|
From Gene Expression Microarrays to Cutting Edge Clinical Decision Making Breakthroughs
|
Devices, Diagnostics, and Drug Development Tools
|
19
|
Innovation Corridor Session III
Tuesday, November 17, 2009
1:30 p.m. – 4:00 p.m.
|
Name/Institution
|
Title
|
Category
|
Poster Number
|
|
Christopher J. Ferrante
TRIM-edicine, Inc.
|
MG53 Nucleates Assembly of Cell Membrane Repair Machinery
|
Technologies and Targets for the Treatments of Tomorrow
|
1 |
|
Marie-Céline Frantz
University of Pittsburgh
|
Gramicidin S-based Mitochondrial Targeting Agents
|
Technologies and Targets for the Treatments of Tomorrow
|
2 |
|
Marc Horn
Prospect Biosystems, Inc.
|
Evaluation of GRP 78 as a Potential Prostate Cancer Biomarker from Needle Core Biopsy Tissue Samples Following a Step-Wise Density Based Subcellular Fractionation
|
Devices, Diagnostics, and Drug Development Tools
|
3 |
|
Innovation Corridor Poster Winner
Joseph Z. Huang, Ph.D.
MicroDysis, Inc.
|
Fluidic Nano-Spot Array For Protein Analysis
|
Devices, Diagnostics, and Drug Development Tools
|
4 |
|
Brad Kern
Princeton University, Molecular Biology
|
Nanoparticles for the Delivery of Hydrophobic Drugs
|
Novel Therapeutic Agents and Delivery Systems
|
5 |
|
Innovation Corridor Poster Winner
Joseph Latino
AquiSci, Inc.
|
Novel Ischemic Stroke Treatment – Inflammation Reduction through Induced Apoptotic Leukocyte Infusion
|
Devices, Diagnostics, and Drug Development Tools
|
7 |
|
John T. Lee
The Wistar Institute
|
Potentiation of p53 Function in Melanoma: Shifting the Current Paradigm Using High-throughput Screening
|
Technologies and Targets for the Treatments of Tomorrow
|
8 |
|
Maria L. Maccecchini
QR Pharma, Inc.
|
Posiphen®: A Clinical Alzheimer Agent that Lowers Amyloid Precursor Protein As Well As Acetylcholinesterase Levels
|
Novel Therapeutic Agents and Delivery Systems
|
9 |
|
Anne-Marie Maman
PhOx Diagnostics, Inc.
|
A Truly Rapid System for the Detection of Live Bacteria in Fresh Food
|
Devices, Diagnostics, and Drug Development Tools
|
10 |
|
Alexey Melishchuk
Drexel University
|
Quantitative Prediction of Diabetic Wound Healing and Detection of Pressure Ulcers
|
Devices, Diagnostics, and Drug Development Tools
|
11 |
|
Kristofer Moffett
Locus Pharmaceuticals, Inc.
|
Development of a Selective DFG-out p38 Kinase Inhibitor by a Combined Computational and Medicinal Chemistry Approach
|
Technologies and Targets for the Treatments of Tomorrow
|
12 |
|
Sanford A. Roth
Medsonics US, Inc.
|
Quantitative Ultrasound System for Bone Fracture Detection and Monitoring
|
Devices, Diagnostics, and Drug Development Tools
|
13 |
|
Innovation Corridor Poster Winner
Annette M. Tobia, Ph.D., J.D.
Dynamis Therapeutics, Inc
|
Targeting Glycation as a Treatment for Diabetes Complications
|
Technologies and Targets for the Treatments of Tomorrow
|
14 |
|
Xinhui Wang, Ph.D.
University of Pittsburgh Cancer Institute
|
CSPG4 as a New Target for Antibody-based Immunotherapy of Triple Negative Breast Cancer and Melanoma
|
Technologies and Targets for the Treatments of Tomorrow
|
15 |
|
Zia Khan
Princeton University
|
Algorithms for Large-Scale LC/MS/MS-Based Molecular Biomarker Discovery
|
Devices, Diagnostics, and Drug Development Tools
|
16 |
|
